cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide

C19H15F2N5O2 — CID 164520385

IUPACcis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide
SMILESCOc1c(F)cc2[nH]ncc2c1-c1ccn2nc(NC(=O)[C@@H]3C[C@@H]3F)cc2c1
InChIInChI=1S/C19H15F2N5O2/c1-28-18-14(21)7-15-12(8-22-24-15)17(18)9-2-3-26-10(4-9)5-16(25-26)23-19(27)11-6-13(11)20/h2-5,7-8,11,13H,6H2,1H3,(H,22,24)(H,23,25,27)/t11-,13+/m1/s1
InChIKeyPVFMOGFGKMGXSF-YPMHNXCESA-N
MW383.36 g/mol
LogP3.32
Rot. Bonds4

About cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide

cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide (PubChem CID 164520385) has the molecular formula C19H15F2N5O2 and a molecular weight of 383.36 g/mol. Its IUPAC name is cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide.

Molecular Properties

Compound Namecis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide
PubChem CID164520385
Molecular FormulaC19H15F2N5O2
Molecular Weight383.36 g/mol
Exact Mass383.12
IUPAC Namecis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide
SMILESCOc1c(F)cc2[nH]ncc2c1-c1ccn2nc(NC(=O)[C@@H]3C[C@@H]3F)cc2c1
InChIInChI=1S/C19H15F2N5O2/c1-28-18-14(21)7-15-12(8-22-24-15)17(18)9-2-3-26-10(4-9)5-16(25-26)23-19(27)11-6-13(11)20/h2-5,7-8,11,13H,6H2,1H3,(H,22,24)(H,23,25,27)/t11-,13+/m1/s1
InChIKeyPVFMOGFGKMGXSF-YPMHNXCESA-N
XLogP3.32
TPSA84.31 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500383.36
LogP ≤ 53.32
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide?
The IUPAC name of cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide (CID 164520385) is cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide.
What is the SMILES notation for cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide?
The canonical SMILES for cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide is COc1c(F)cc2[nH]ncc2c1-c1ccn2nc(NC(=O)[C@@H]3C[C@@H]3F)cc2c1.
What is the InChIKey of cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide?
The InChIKey is PVFMOGFGKMGXSF-YPMHNXCESA-N. The full InChI is InChI=1S/C19H15F2N5O2/c1-28-18-14(21)7-15-12(8-22-24-15)17(18)9-2-3-26-10(4-9)5-16(25-26)23-19(27)11-6-13(11)20/h2-5,7-8,11,13H,6H2,1H3,(H,22,24)(H,23,25,27)/t11-,13+/m1/s1.
What are the key properties of cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide?
cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide has a molecular weight of 383.36 g/mol, XLogP of 3.32, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for cis-(1S,2S)-2-fluoro-N-[5-(6-fluoro-5-methoxy-1H-indazol-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxamide is sourced from PubChem (CID 164520385), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).